BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25772471)

  • 1. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
    Crane AM; Kramer P; Bui JH; Chung WJ; Li XS; Gonzalez-Garay ML; Hawkins F; Liao W; Mora D; Choi S; Wang J; Sun HC; Paschon DE; Guschin DY; Gregory PD; Kotton DN; Holmes MC; Sorscher EJ; Davis BR
    Stem Cell Reports; 2015 Apr; 4(4):569-77. PubMed ID: 25772471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
    Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
    Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs.
    Firth AL; Menon T; Parker GS; Qualls SJ; Lewis BM; Ke E; Dargitz CT; Wright R; Khanna A; Gage FH; Verma IM
    Cell Rep; 2015 Sep; 12(9):1385-90. PubMed ID: 26299960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction.
    Suzuki S; Crane AM; Anirudhan V; Barillà C; Matthias N; Randell SH; Rab A; Sorscher EJ; Kerschner JL; Yin S; Harris A; Mendel M; Kim K; Zhang L; Conway A; Davis BR
    Mol Ther; 2020 Jul; 28(7):1684-1695. PubMed ID: 32402246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P.F508del editing in cells from cystic fibrosis patients.
    Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
    PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening for Modulators of CFTR Activity Based on Genetically Engineered Cystic Fibrosis Disease-Specific iPSCs.
    Merkert S; Schubert M; Olmer R; Engels L; Radetzki S; Veltman M; Scholte BJ; Zöllner J; Pedemonte N; Galietta LJV; von Kries JP; Martin U
    Stem Cell Reports; 2019 Jun; 12(6):1389-1403. PubMed ID: 31080112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis.
    King NE; Suzuki S; Barillà C; Hawkins FJ; Randell SH; Reynolds SD; Stripp BR; Davis BR
    Hum Gene Ther; 2020 Sep; 31(17-18):956-972. PubMed ID: 32741223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
    Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
    Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.
    Sebastiano V; Maeder ML; Angstman JF; Haddad B; Khayter C; Yeo DT; Goodwin MJ; Hawkins JS; Ramirez CL; Batista LF; Artandi SE; Wernig M; Joung JK
    Stem Cells; 2011 Nov; 29(11):1717-26. PubMed ID: 21898685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclease-mediated double-strand break (DSB) enhancement of small fragment homologous recombination (SFHR) gene modification in human-induced pluripotent stem cells (hiPSCs).
    Sargent RG; Suzuki S; Gruenert DC
    Methods Mol Biol; 2014; 1114():279-90. PubMed ID: 24557910
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.
    Bednarski C; Tomczak K; Vom Hövel B; Weber WM; Cathomen T
    PLoS One; 2016; 11(8):e0161072. PubMed ID: 27526025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells for treating cystic fibrosis: State of the science.
    Pollard BS; Pollard HB
    Pediatr Pulmonol; 2018 Nov; 53(S3):S12-S29. PubMed ID: 30062693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
    Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.
    Dębczyński M; Mojsak D; Tamburro S; Baldassari S; Musante I; Casciaro R; Ciciriello F; Zara F; Scudieri P; Gorrieri G
    Stem Cell Res; 2023 Oct; 72():103232. PubMed ID: 37865062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells.
    Yan Z; Vorhies K; Feng Z; Park SY; Choi SH; Zhang Y; Winter M; Sun X; Engelhardt JF
    Hum Gene Ther; 2022 Oct; 33(19-20):1023-1036. PubMed ID: 35686451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
    Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.